Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K052932
    Manufacturer
    Date Cleared
    2005-11-04

    (16 days)

    Product Code
    Regulation Number
    866.3220
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Device Name :

    CRYPTOSPORIDIUM II

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The CRYPTOSPORIDIUM II test is an enzyme immunoassay for the qualitative detection of Cryptosporidium oocyst antigen in human fecal specimens. It is indicated for use as an aid in the diagnosis of patients with diarrhea suspected of Cryptosporidium gastrointestinal infection. FOR IN VITRO DIAGNOSTIC USE.

    Device Description

    Not Found

    AI/ML Overview

    The provided text is a 510(k) premarket notification letter from the FDA, granting market clearance for the "CRYPTOSPORIDIUM II" device. It outlines the device's indications for use and states that it has been deemed substantially equivalent to a legally marketed predicate device.

    However, the provided text does not contain the detailed study information required to answer your specific questions regarding acceptance criteria, reported device performance, sample sizes, ground truth establishment, expert qualifications, or MRMC comparative effectiveness studies. This type of information is typically found in the 510(k) summary or the actual study reports submitted to the FDA, not in the clearance letter itself.

    The letter explicitly states: "We have reviewed your Section 510(k) premarket notification of intent to market the device we have and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA)." This indicates that the device was cleared based on substantial equivalence, not necessarily on a de novo study proving it meets specific acceptance criteria with detailed performance metrics in the way you've outlined for an AI/imaging device.

    Therefore, I cannot populate the table or answer the subsequent questions based solely on the provided text. To get this information, you would need to access the full 510(k) submission for K052932, which might be publicly available through FDA databases or by request.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1